Zurich Insurance Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.5M Buy
99,069
+58,257
+143% +$44.6M 0.6% 33
2025
Q4
$31.5M Sell
40,812
-108,992
-73% -$74M 0.22% 119
2025
Q3
$84.2M Buy
149,804
+127,153
+561% +$71.9M 0.6% 48
2025
Q2
$11.9M Buy
+22,651
New +$12.6M 0.09% 130
2025
Q1
Sell
-23,784
Closed -$16.9M 292
2024
Q4
$16.9M Sell
23,784
-39,857
-63% -$33.4M 0.14% 129
2024
Q3
$66.9M Sell
63,641
-28,709
-31% -$31.9M 0.57% 60
2024
Q2
$97.1M Buy
92,350
+39,382
+74% +$38.2M 0.84% 30
2024
Q1
$51M Buy
52,968
+20,736
+64% +$19.7M 0.47% 73
2023
Q4
$28.3M Sell
32,232
-47,092
-59% -$38.8M 0.29% 103
2023
Q3
$65.3M Buy
+79,324
New +$62.3M 0.69% 49
2019
Q4
Sell
-14,187
Closed -$3.94M 434
2019
Q3
$3.94M Buy
14,187
+468
+3% +$138K 0.07% 277
2019
Q2
$4.29M Buy
13,719
+541
+4% +$180K 0.09% 262
2019
Q1
$5.41M Sell
13,178
-15,620
-54% -$6.43M 0.12% 219
2018
Q4
$10.8M Buy
28,798
+5,471
+23% +$2M 0.26% 114
2018
Q3
$9.43M Sell
23,327
-75
-0.3% -$28.5K 0.2% 140
2018
Q2
$8.07M Buy
23,402
+13,625
+139% +$4.26M 0.18% 162
2018
Q1
$3.37M Sell
9,777
-1,443
-13% -$502K 0.08% 310
2017
Q4
$4.22M Buy
11,220
+1,379
+14% +$558K 0.1% 247
2017
Q3
$4.4M Sell
9,841
-2,276
-19% -$1.08M 0.12% 202
2017
Q2
$5.95M Sell
12,117
-561
-4% -$245K 0.17% 147
2017
Q1
$4.91M Sell
12,678
-483
-4% -$179K 0.14% 179
2016
Q4
$4.83M Buy
13,161
+945
+8% +$359K 0.15% 170
2016
Q3
$4.91M Buy
12,216
+3,539
+41% +$1.42M 0.16% 166
2016
Q2
$3.03M Buy
8,677
+1,442
+20% +$555K 0.11% 221
2016
Q1
$2.61M Sell
7,235
-11,830
-62% -$4.87M 0.09% 238
2015
Q4
$10.3M Buy
19,065
+1,271
+7% +$689K 0.37% 81
2015
Q3
$8.28M Buy
+17,794
New +$9.56M 0.3% 111

Other funds holding REGN